Oct 31, 2022 / 02:00PM GMT
Tara Sobierajski -
Good morning, and welcome to the Cyclacel Pharmaceuticals' R&D Day. (Operator Instructions) If you'd like to submit a question, you may do so by using the Q&A text box at the bottom of the webcast player or by e-mailing your questions to [email protected].
As a reminder, this call is being recorded and a replay will be made available on the Cyclacel's website following the conclusion of the event. I'd now like to turn the call over to Spiro Rombotis, President and Chief Executive Officer of Cyclacel Pharmaceuticals. Please go ahead, Spiro.
Spiro George Rombotis - Cyclacel Pharmaceuticals, Inc. - President, CEO & Executive Director
Thank you, Tara, and good morning, everyone. Let me also extend a warm welcome to those of you who'll be listening by webcast. Before I make my further remarks and so would my colleagues, I would like to draw your attention to the usual disclaimer regarding forward-looking statements we will be making about our programs, which are subject to change. And I would refer you to our filings with
Cyclacel Pharmaceuticals Inc Research & Development Day Transcript
Oct 31, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers